Catyalyst Pharma (CPRX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.43 --0%
Revenue Growth %: +6.2%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
FOMI, FLES, IMMR, More
Revenue Growth %: +6.2%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
FOMI, FLES, IMMR, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
- Prabhudas Lilladher Starts Acutaas Chemicals (ACUTAAS:IN) at Accumulate (2)
- Raymond James Upgrades CVB Financial (CVBF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
